The relationships between circulating biomarkers of iron deficiency and outcomes in patients with heart failure and reduced ejection fraction: insights from DAPA-HF

被引：0
|
作者：
Docherty, Kieran
Brennan, Alice
Sukumar, Shivasankar
Welsh, Paul
Ponikowski, Piotr
Petrie, Mark
Cleland, John
Solomon, Scott
Jhund, Pardeep
McMurray, John
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4141380
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4141380
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction
    Sung, Hsiao-Ping
    Hsu, Chien-Yi
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Liao, Chia-Te
    Chung, Fa-Po
    Ko, Shao-Lun
    Huang, Chun-Yao
    Lin, Kuan-Chia
    Chang, Hung-Yu
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (08) : 725 - 731
  • [42] DAPA-HF: does dapagliflozin provide 'bang for your buck' as a treatment forheart failure with reduced ejection fraction?
    Cowie, Martin R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) : 2157 - 2159
  • [43] Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial
    Berg, David D.
    Docherty, Kieran F.
    Sattar, Naveed
    Jarolim, Petr
    Welsh, Paul
    Jhund, Pardeep S.
    Anand, Inder S.
    Chopra, Vijay
    de Boer, Rudolf A.
    Kosiborod, Mikhail N.
    Nicolau, Jose C.
    O'Meara, Eileen
    Schou, Morten
    Hammarstedt, Ann
    Langkilde, Anna-Maria
    Lindholm, Daniel
    Sjostrand, Mikaela
    McMurray, John J. V.
    Sabatine, Marc S.
    Morrow, David A.
    CIRCULATION, 2022, 145 (03) : 158 - 169
  • [44] Translating findings from the landmark DAPA-HF study: a multinational cost-effectiveness analysis of dapagliflozin in the treatment of heart failure with reduced ejection fraction
    Mcmurray, J. J. V.
    Mcewan, P.
    Darlington, O.
    Jhund, P.
    Docherty, K.
    Bohm, M.
    Petrie, M.
    Bergenheim, K.
    Qin, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 272 - 273
  • [45] Pulse pressure and outcomes in heart failure with reduced ejection fraction: insights from PARADIGM-HF
    Chen, C. H.
    Ramparsad, N. T.
    Greenlaw, N.
    Jhund, P. S.
    Shi, V. C.
    Rouleau, J. L.
    Solomon, S. D.
    Swedberg, K.
    Zile, M. R.
    Packer, M.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2016, 37 : 920 - 920
  • [46] Relationship between iron deficiency and frailty syndrome in patients with heart failure with reduced ejection fraction
    Soloch, A.
    Sawczak, F.
    Szubarga, A.
    Cierzniak, M.
    Kukfisz, A.
    Szczechla, M.
    Krysztofiak, H.
    Tomaszewska, M.
    Dudek, M.
    Straburzynska-Migaj, E.
    Kaluzna-Oleksy, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 340 - 340
  • [47] Iron Deficiency: A Silent Threat in Patients With Heart Failure With Reduced Ejection Fraction
    Sarate, Nitin
    Sonawane, Rahul
    Pai, Vinayak
    Karatela, Shifa
    Mulkalwar, Alhad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [48] Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial
    Butt, Jawad H.
    Adamson, Carly
    Docherty, Kieran F.
    de Boer, Rudolf A.
    Petrie, Mark C.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Maria Langkilde, Anna
    Lindholm, Daniel
    Martinez, Felipe A.
    Bengtsson, Olof
    Schou, Morten
    O'Meara, Eileen
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Kober, Lars
    CIRCULATION-HEART FAILURE, 2021, 14 (12) : 1305 - 1318
  • [49] Intravenous iron therapy and circulating biomarkers of inflammation in men with heart failure with reduced ejection fraction
    Drozd, M.
    Tkaczyszyn, M.
    Wegrzynowska-Teodorczyk, K.
    Kasztura, M.
    Dziegala, M.
    Kobak, K.
    Banasiak, W.
    Ponikowski, R.
    Jankowska, E. A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1167 - 1167
  • [50] Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER data
    Davis, Jason A.
    Booth, David
    Mcewan, Phil
    Solomon, Scott D.
    Mcmurray, John J. V.
    de Boer, Rudolf A.
    Comin-Colet, Josep
    Bachus, Erasmus
    Chen, Jieling
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (03) : 664 - 673
12345